Joshua Davis

Menzies School of Health Research

Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joshua Davis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Northern Territory Medicine & Life Sciences
Sepsis Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Infection Medicine & Life Sciences
Staphylococcus aureus Medicine & Life Sciences
Lactams Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus Medicine & Life Sciences
Bacteremia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal

Campbell, A. J., Dotel, R., Blyth, C. C., Davis, J. S., Tong, S. Y. C. & Bowen, A. C., 1 Jan 2019, In : The Journal of antimicrobial chemotherapy. 74, 1, p. 1-5 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Protein Synthesis Inhibitors
Staphylococcus aureus
Anti-Bacterial Agents

A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III

Lipman, J., Brett, S. J., De Waele, J. J., Cotta, M. O., Davis, J. S., Finfer, S., Glass, P., Knowles, S., McGuinness, S., Myburgh, J., Paterson, D. L., Peake, S., Rajbhandari, D., Rhodes, A., Roberts, J. A., Shirwadkar, C., Starr, T., Taylor, C., Billot, L. & Dulhunty, J. M., 1 Mar 2019, In : Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 21, 1, p. 63-68 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Critical Illness
Randomized Controlled Trials
Random Allocation

Australia's response to the global threat of antimicrobial resistance: past, present and future

Davis, J. S., Jones, C. A., Cheng, A. C. & Howden, B. P., Aug 2019, In : Medical Journal of Australia. 211, 3, p. 106-108.e1 4 p.

Research output: Contribution to journalComment/debateResearchpeer-review

Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study

Henderson, A., Harris, P., Hartel, G., Paterson, D., Turnidge, J., Davis, J. S. & Tong, S. Y. C., 7 Jun 2019, In : International Journal of Antimicrobial Agents. p. 1-5 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Penicillin G
Staphylococcus aureus
Cohort Studies

CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: Study protocol for a randomised controlled trial

Dotel, R., Tong, S. Y. C., Bowen, A., Nelson, J. N., O'sullivan, M. V. N., Campbell, A. J., McMullan, B. J., Britton, P. N., Francis, J. R., Eisen, D. P., Robinson, O., Manning, L. & Davis, J. S., 13 Jun 2019, In : Trials. 20, 1, p. 1-13 13 p., 353.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Staphylococcus aureus
Randomized Controlled Trials